Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Combined TCR-seq and single-cell RNA-seq reveal distinct origins for antiviral immunity after post-transplant cyclophosphamide and tac/MTX gvhd prophylaxis: Results from the BMT CTN 1801 study

Blood (2025) 146 (Supplement 1): 818.

https://doi.org/10.1182/blood-2025-818

Published: 2025

Journal Articles

Large-Scale Post-Transplant TCR Deep Sequencing Reveals a Major T Cell Diversity Bottleneck with Post-Transplant Cyclophosphamide with Implications for Both Efficacy and Toxicity: Results of the BMT CTN 1801 Study

Blood (2023) 142 (Supplement 1): 475.

https://doi.org/10.1182/blood-2023-188032

Published: 2023

Journal Articles

Feasibility and Preliminary Findings of a Novel, Patient-Centric Registry Model to Address Real-World Care Questions for Patients with Hematologic Malignancies

Sophia C Cornew, Anthony B Cardillo, Louis J DeGennaro, Paul A Fields, Lore M Gruenbaum, Hana Littleford, Richard L Martin, Gwen L Nichols, Amanda C Nottke, Conner M O'Brien, Sneha T Reddy, Rhonda Rosenbaum, Larry A Saltzman, Catherine Sanders, Jun Xu, Lee M Greenberger

Blood (2022) 140 (Supplement 1): 8044–8045.

https://doi.org/10.1182/blood-2022-166222

Published: 2022

Journal Articles

Treating MRD Positivity in Multiple Myeloma: An Allogeneic GM-CSF-Based Vaccine in Combination with Lenalidomide Induces Long-Term Remissions in Patients with Low Disease Burden

Luca Biavati, MD, Carol Ann Huff, MD, Anna Ferguson, BSN, RN, Lakshmi Rudraraju, MS, Cristina Zucchinetti, Rachel Gittelman, Sarah Johnson, Catherine Sanders, Abbas Abbas Ali, MD, Kimberly Noonan, PhD MPH, Ivan M. Borrello, MD

Blood (2020) 136 (Supplement 1): 8.

https://doi.org/10.1182/blood-2020-142620

Published: 2020

Journal Articles

An Allogeneic GM-CSF-Based Vaccine in Combination with Lenalidomide Induces Durable Remissions and Sustained Immunological Responses in Multiple Myeloma

Luca Biavati, MD, Anna Ferguson, BSN, RN, Carol Ann Huff, MD, Lakshmi Rudraraju, MS, Rachel Gittelman, Sarah Johnson, Catherine Sanders, Syed Abbas Ali, MD, Kimberly Noonan, PhD MPH, Ivan M. Borrello, MD

Blood (2019) 134 (Supplement_1): 1895.

https://doi.org/10.1182/blood-2019-128430

Published: 2019

Journal Articles

Fractal Organization of the Human T Cell Repertoire in Health and Following Stem Cell Transplantation

Jeremy Meier, Allison F Hazlett, MS, Kassi Avent, MS, Jennifer Berrie, Kyle Payne, David Hamm, MS, Cindy Desmarais, PhD, Catherine Sanders, PhD, Kevin T Hogan, PhD, Steven Grant, MD, Kellie J Archer, PhD, Masoud H Manjili, DVM, PhD, Catherine Roberts, PhD, Amir A Toor, MD

Blood (2012) 120 (21): 4193.

https://doi.org/10.1182/blood.V120.21.4193.4193

Published: 2012

Journal Articles

Characterization of the MHC class I cross-presentation pathway for cell-associated antigens by human dendritic cells

Jean Francois Fonteneau, Daniel G. Kavanagh, Margareta Lirvall, Catherine Sanders, Timothy L. Cover, Nina Bhardwaj, Marie Larsson

Blood (2003) 102 (13): 4448–4455.

https://doi.org/10.1182/blood-2003-06-1801

Published: 2003

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Combined TCR-seq and single-cell RNA-seq reveal distinct origins for antiviral immunity after post-transplant cyclophosphamide and tac/MTX gvhd prophylaxis: Results from the BMT CTN 1801 study

Large-Scale Post-Transplant TCR Deep Sequencing Reveals a Major T Cell Diversity Bottleneck with Post-Transplant Cyclophosphamide with Implications for Both Efficacy and Toxicity: Results of the BMT CTN 1801 Study

Feasibility and Preliminary Findings of a Novel, Patient-Centric Registry Model to Address Real-World Care Questions for Patients with Hematologic Malignancies

Treating MRD Positivity in Multiple Myeloma: An Allogeneic GM-CSF-Based Vaccine in Combination with Lenalidomide Induces Long-Term Remissions in Patients with Low Disease Burden

An Allogeneic GM-CSF-Based Vaccine in Combination with Lenalidomide Induces Durable Remissions and Sustained Immunological Responses in Multiple Myeloma

Fractal Organization of the Human T Cell Repertoire in Health and Following Stem Cell Transplantation

Characterization of the MHC class I cross-presentation pathway for cell-associated antigens by human dendritic cells

Email alerts

ASH Publications

American Society of Hematology

Update search

Combined TCR-seq and single-cell RNA-seq reveal distinct origins for antiviral immunity after post-transplant cyclophosphamide and tac/MTX gvhd prophylaxis: Results from the BMT CTN 1801 study

Large-Scale Post-Transplant TCR Deep Sequencing Reveals a Major T Cell Diversity Bottleneck with Post-Transplant Cyclophosphamide with Implications for Both Efficacy and Toxicity: Results of the BMT CTN 1801 Study

Feasibility and Preliminary Findings of a Novel, Patient-Centric Registry Model to Address Real-World Care Questions for Patients with Hematologic Malignancies

Treating MRD Positivity in Multiple Myeloma: An Allogeneic GM-CSF-Based Vaccine in Combination with Lenalidomide Induces Long-Term Remissions in Patients with Low Disease Burden

An Allogeneic GM-CSF-Based Vaccine in Combination with Lenalidomide Induces Durable Remissions and Sustained Immunological Responses in Multiple Myeloma

Fractal Organization of the Human T Cell Repertoire in Health and Following Stem Cell Transplantation

Characterization of the MHC class I cross-presentation pathway for cell-associated antigens by human dendritic cells

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only